InstantQT allows physicians to record the ECG and evaluate patients for potential cardiac abnormalities in less than one minute. When used with the company’s KardiaMobile 6L device and KardiaStation app, the technology provides instant access to feedback. The company says it designed InstantQT to support timely clinical decision-making.
Mountain View, California-based AliveCor’s KardiaMobile 6L offers medical-grade ECG recordings in 30 seconds. The FDA-cleared, portable recording device enables patient-initiated recordings during symptoms, potentially enhancing diagnostic accuracy.
Patients place their fingers on each of the top two electrodes for the device and place the bottom electrode on their left knee or ankle. It provides a reading without any need for undressing, skin preparation, gels or wires. The system then immediately automatically has the ECG evaluated by a proprietary AI algorithm.
Users can access instant feedback on the patient’s QTc value at the point of care through AliveCor’s KardiaStation app as well. The company offers this solution on currently available iOS devices.
“At AliveCor we’re very proud of our legacy in delivering innovative remote cardiac solutions, and today’s launch is further evidence of our commitment to creating new products that can help overcome real-world challenges. The InstantQT solution has the potential to revolutionise the way certain drugs are initiated, streamlining current physician workflows whilst also prioritising patient safety,” said Sean Warren, senior director EMEA, AliveCor.
